Viatris Inc

VTRS · Health Technology · Pharmaceuticals: Major · US

30,000 employees · viatris.com

About

Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide.

Annual results

Reported figures, USD · revenue down 3.0% in 2025

YearRevenueNet incomeNet marginFree cash flow
202514.3B-3.5B-24.6%—
202414.7B-634M-4.3%2.0B
202315.4B54.0M0.4%2.4B
202216.3B2.1B12.8%2.5B
202117.9B-1.3B-7.1%2.5B

Dividends per share

2026 0.48 USD2025 0.48 USD2024 0.48 USD2023 0.48 USD2022 0.48 USD

VTRS in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Viatris Inc are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Viatris Inc (VTRS) — company profile and financials · MarketPulse